116 related articles for article (PubMed ID: 38302832)
1. Synthesis of Novel Acetyl-11-keto-β-boswellic Acid Derivatives as Potential Anti-GBM Agents.
Sun M; Zhang S; Wang J; Du G; Ji T
Chem Biodivers; 2024 Apr; 21(4):e202301979. PubMed ID: 38302832
[TBL] [Abstract][Full Text] [Related]
2. 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase.
Li W; Liu J; Fu W; Zheng X; Ren L; Liu S; Wang J; Ji T; Du G
J Exp Clin Cancer Res; 2018 Jul; 37(1):132. PubMed ID: 29970196
[TBL] [Abstract][Full Text] [Related]
3. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
[TBL] [Abstract][Full Text] [Related]
4. S670, an amide derivative of 3-O-acetyl-11-keto-β-boswellic acid, induces ferroptosis in human glioblastoma cells by generating ROS and inhibiting STX17-mediated fusion of autophagosome and lysosome.
Yang YH; Li W; Ren LW; Yang H; Zhang YZ; Zhang S; Hao Y; Yu DK; Tong RS; Du GH; Shi JY; Wang JH
Acta Pharmacol Sin; 2024 Jan; 45(1):209-222. PubMed ID: 37749236
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity.
Sailer ER; Subramanian LR; Rall B; Hoernlein RF; Ammon HP; Safayhi H
Br J Pharmacol; 1996 Feb; 117(4):615-8. PubMed ID: 8646405
[TBL] [Abstract][Full Text] [Related]
6. Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-β-boswellic acid from Boswellia serrata.
Raja AF; Ali F; Khan IA; Shawl AS; Arora DS; Shah BA; Taneja SC
BMC Microbiol; 2011 Mar; 11():54. PubMed ID: 21406118
[TBL] [Abstract][Full Text] [Related]
7. 3-
Li W; Ren L; Zheng X; Liu J; Wang J; Ji T; Du G
Acta Pharm Sin B; 2020 Feb; 10(2):301-312. PubMed ID: 32082975
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of boswellic acid derivatives as potent VEGFR-2 inhibitors.
Shen S; Xu X; Liu Z; Liu J; Hu L
Bioorg Med Chem; 2015 May; 23(9):1982-93. PubMed ID: 25819335
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of new boswellic acid derivatives as potential antiproliferative agents.
Shamraiz U; Hussain H; Ur Rehman N; Al-Shidhani S; Saeed A; Khan HY; Khan A; Fischer L; Csuk R; Badshah A; Al-Rawahi A; Hussain J; Al-Harrasi A
Nat Prod Res; 2020 Jul; 34(13):1845-1852. PubMed ID: 30691289
[TBL] [Abstract][Full Text] [Related]
10. Discovery of New Boswellic Acid Hybrid 1
Rehman NU; Ullah S; Alam T; Halim SA; Mohanta TK; Khan A; Anwar MU; Csuk R; Avula SK; Al-Harrasi A
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259377
[TBL] [Abstract][Full Text] [Related]
11. New derivatives of 11-keto-β-boswellic acid (KBA) induce apoptosis in breast and prostate cancers cells.
Bini Araba A; Ur Rehman N; Al-Araimi A; Al-Hashmi S; Al-Shidhani S; Csuk R; Hussain H; Al-Harrasi A; Zadjali F
Nat Prod Res; 2021 Mar; 35(5):707-716. PubMed ID: 30931626
[TBL] [Abstract][Full Text] [Related]
12. Ring A-modified Derivatives from the Natural Triterpene 3-O-acetyl-11-keto-β-Boswellic Acid and their Cytotoxic Activity.
Li T; Fan P; Ye Y; Luo Q; Lou H
Anticancer Agents Med Chem; 2017; 17(8):1153-1167. PubMed ID: 27928954
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel 2-substituted 11-keto-boswellic acid heterocyclic derivatives as anti-prostate cancer agents with Pin1 inhibition ability.
Li K; Li L; Wang S; Li X; Ma T; Liu D; Jing Y; Zhao L
Eur J Med Chem; 2017 Jan; 126():910-919. PubMed ID: 27997878
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new analogs of AKBA and evaluation of their anti-inflammatory activities.
Meka B; Ravada SR; Murali Krishna Kumar M; Purna Nagasree K; Golakoti T
Bioorg Med Chem; 2017 Feb; 25(4):1374-1388. PubMed ID: 28110820
[TBL] [Abstract][Full Text] [Related]
15. Measurement of 3-acetyl-11-keto-beta-boswellic acid and 11-keto-beta-boswellic acid in Boswellia serrata Supplements Administered to Dogs.
Miscioscia E; Shmalberg J; Scott KC
BMC Vet Res; 2019 Aug; 15(1):270. PubMed ID: 31370899
[TBL] [Abstract][Full Text] [Related]
16. 3-acetyl-11-keto-beta-boswellic acid decreases the malignancy of taxol resistant human ovarian cancer by inhibiting multidrug resistance (MDR) proteins function.
Jin L; Yingchun W; Zhujun S; Yinan W; Dongchen W; Hui Y; Xi Y; Wanzhou Z; Buluan Z; Jinhua W
Biomed Pharmacother; 2019 Aug; 116():108992. PubMed ID: 31129513
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an acetyl-11-keto-beta-boswellic acid and arachidonate-binding regulatory site of 5-lipoxygenase using photoaffinity labeling.
Sailer ER; Schweizer S; Boden SE; Ammon HP; Safayhi H
Eur J Biochem; 1998 Sep; 256(2):364-8. PubMed ID: 9760176
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 3-
Li C; He Q; Xu Y; Lou H; Fan P
ACS Omega; 2022 Mar; 7(11):9853-9866. PubMed ID: 35350335
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of ring A modified 11-keto-boswellic acid derivatives as Pin1 inhibitors with remarkable anti-prostate cancer activity.
Huang M; Li A; Zhao F; Xie X; Li K; Jing Y; Liu D; Zhao L
Bioorg Med Chem Lett; 2018 Oct; 28(19):3187-3193. PubMed ID: 30153964
[TBL] [Abstract][Full Text] [Related]
20. Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties.
Liu YQ; Wang SK; Xu QQ; Yuan HQ; Guo YX; Wang Q; Kong F; Lin ZM; Sun DQ; Wang RM; Lou HX
Acta Pharmacol Sin; 2019 May; 40(5):689-698. PubMed ID: 30171201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
